Similar articles for PMID: 10826865

Year	Number of Results
1973	1
1974	1
1986	1
1988	1
1989	1
1990	1
1991	1
1992	3
1993	1
1994	1
1995	2
1996	6
1997	3
1998	7
1999	8
2000	5
2001	4
2002	6
2003	6
2004	7
2005	3
2006	3
2007	2
2008	1
2010	2
2011	1
2012	1
2014	2
2015	3
2017	1
2018	2
2019	1
2021	1
2022	0

1

Impact of vaginal antifungal products on utilization of health care services: evidence from physician visits.

Lipsky MS, Waters T, Sharp LK. Lipsky MS, et al. J Am Board Fam Pract. 2000 May-Jun;13(3):178-82. doi: 10.3122/15572625-13-3-178. J Am Board Fam Pract. 2000. PMID: 10826865

2

The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.

Gurwitz JH, McLaughlin TJ, Fish LS. Gurwitz JH, et al. Health Serv Res. 1995 Dec;30(5):672-85. Health Serv Res. 1995. PMID: 8537226 Free PMC article.

3

Trends in prescribing for vulvovaginal candidiasis in the United States.

McCaig LF, McNeil MM. McCaig LF, et al. Pharmacoepidemiol Drug Saf. 2005 Feb;14(2):113-20. doi: 10.1002/pds.960. Pharmacoepidemiol Drug Saf. 2005. PMID: 15386715

4

The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.

Andrade SE, Gurwitz JH, Fish LS. Andrade SE, et al. Med Care. 1999 Apr;37(4):424-30. doi: 10.1097/00005650-199904000-00012. Med Care. 1999. PMID: 10213023

5

The use of over-the-counter antifungal vaginitis preparations by college students.

Lipsky MS, Taylor C. Lipsky MS, et al. Fam Med. 1996 Jul-Aug;28(7):493-5. Fam Med. 1996. PMID: 8818620

6

Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.

Roy S, Caillouette JC, Faden JS, Roy T, Ramos DE. Roy S, et al. Infect Dis Obstet Gynecol. 2003;11(4):209-16. doi: 10.1080/10647440300025523. Infect Dis Obstet Gynecol. 2003. PMID: 15108867 Free PMC article.

7

American Pharmaceutical Association review of literature on prescription to over-the-counter drug switches.

Schulke DG. Schulke DG. Clin Ther. 1998;20 Suppl C:C124-33. doi: 10.1016/s0149-2918(98)80017-9. Clin Ther. 1998. PMID: 9915099 Review.

8

Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents.

Taylor CA, Lipsky MS. Taylor CA, et al. J Fam Pract. 1994 Feb;38(2):157-60. J Fam Pract. 1994. PMID: 8308507

9

Vaginitis: making sense of over-the-counter treatment options.

Angotti LB, Lambert LC, Soper DE. Angotti LB, et al. Infect Dis Obstet Gynecol. 2007;2007:97424. doi: 10.1155/2007/97424. Infect Dis Obstet Gynecol. 2007. PMID: 18253469 Free PMC article. Review.

10

Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.

Mårdh PA, Wågström J, Landgren M, Holmén J. Mårdh PA, et al. Infect Dis Obstet Gynecol. 2004 Jun;12(2):91-7. doi: 10.1080/10647440400003873. Infect Dis Obstet Gynecol. 2004. PMID: 15739823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed